AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764Globe Newswire•20/08/2026•07:00 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
